
2025 HDBuzz Prize: On the Frontlines: Trusting the Hall Monitors of the Cell
We’re proud to announce Chloe Langridge as a 2025 HDBuzz Prize winner! A protein called SGTA shows promise as a target in HD therapeutics. Researchers find that increasing levels of SGTA in the cell helps reduce signs of HD.
Think about the last time you were stressed. What did you do to feel better? For many of us, it’s talking through our frustrations. Getting rid of things that stress out our cells also requires good communication. The central communicators? Chaperonechaperone chaperone proteins help other proteins to fold correctly, and can protect proteins against damage proteins. Chaperonechaperone chaperone proteins help other proteins to fold correctly, and can protect proteins against damage proteins are just like the chaperoneschaperone chaperone proteins help other proteins to fold correctly, and can protect proteins against damage at a school dance. They direct misbehaving proteins to where they need to go and keep them from causing more chaos in the cell. Proteins can be misbehaving in cells for many different reasons, but in diseases like HD, the expanded huntingtin proteinhuntingtin protein The protein produced by the HD gene. is thought to misbehave because it isn’t folded properly and clumps together.
A study identified the co-chaperonechaperone chaperone proteins help other proteins to fold correctly, and can protect proteins against damage SGTA as an expanded huntingtin interactor in HD model cells and mice. Co-chaperoneschaperone chaperone proteins help other proteins to fold correctly, and can protect proteins against damage are like the hall monitors that report to chaperoneschaperone chaperone proteins help other proteins to fold correctly, and can protect proteins against damage. SGTA is potentially a promising therapeutic target because it is not essential for cellular processes and increases survival of patients of other protein misfolding diseases. Let’s get into this study and what they found.
Finding the Troublemakers
In HD, expanded huntingtin clumps together into groups of misfolded proteins called aggregatesaggregate Lumps of protein that form inside cells in Huntington’s disease and some other degenerative diseases. Chaperoneschaperone chaperone proteins help other proteins to fold correctly, and can protect proteins against damage target misfolded proteins to minimize the chaos in the cell. Expanded huntingtin aggregatesaggregate Lumps of protein that form inside cells in Huntington’s disease and some other degenerative diseases are like magnets for chaperoneschaperone chaperone proteins help other proteins to fold correctly, and can protect proteins against damage. Despite this, chaperoneschaperone chaperone proteins help other proteins to fold correctly, and can protect proteins against damage fail to control the chaos caused by expanded huntingtin aggregatesaggregate Lumps of protein that form inside cells in Huntington’s disease and some other degenerative diseases.
This is a key problem with using chaperoneschaperone chaperone proteins help other proteins to fold correctly, and can protect proteins against damage as a therapeutic target, but there are other issues too. Like the chaperoneschaperone chaperone proteins help other proteins to fold correctly, and can protect proteins against damage at a school dance, catching the chaos is not their only job, they also have to setup the dance. Chaperoneschaperone chaperone proteins help other proteins to fold correctly, and can protect proteins against damage help make new proteins, direct traffic in cells by sending specialized proteins to specific locations, and clean up by targeting old and damaged proteins to the cell’s trash can. Boosting the amount of a chaperonechaperone chaperone proteins help other proteins to fold correctly, and can protect proteins against damage with a therapy doesn’t seem to help in HD. Having too many chaperoneschaperone chaperone proteins help other proteins to fold correctly, and can protect proteins against damage can be too much of a good thing and instead of productively removing the problem, we’ve introduced more chaos.

Getting Caught by the Hall Monitors
Here’s the good news. There’s a subset of helper proteins called co-chaperoneschaperone chaperone proteins help other proteins to fold correctly, and can protect proteins against damage that work with chaperoneschaperone chaperone proteins help other proteins to fold correctly, and can protect proteins against damage. The role of co-chaperoneschaperone chaperone proteins help other proteins to fold correctly, and can protect proteins against damage is to serve as the first response. Like hall monitors, they find the sneaky misfolded proteins and stop them from causing more problems. The sneaky protein is reprimanded by the co-chaperonechaperone chaperone proteins help other proteins to fold correctly, and can protect proteins against damage and delivered to the chaperonechaperone chaperone proteins help other proteins to fold correctly, and can protect proteins against damage. The chaperonechaperone chaperone proteins help other proteins to fold correctly, and can protect proteins against damage is ultimately who decides what to do with the protein, but the co-chaperonechaperone chaperone proteins help other proteins to fold correctly, and can protect proteins against damage often helps the chaperonechaperone chaperone proteins help other proteins to fold correctly, and can protect proteins against damage find the protein, hence the name co-chaperonechaperone chaperone proteins help other proteins to fold correctly, and can protect proteins against damage.
A study has identified the co-chaperonechaperone chaperone proteins help other proteins to fold correctly, and can protect proteins against damage SGTA to be of particular interest as a new star hall monitor. Kubota and colleagues found that SGTA associates with the huntingtin aggregatesaggregate Lumps of protein that form inside cells in Huntington’s disease and some other degenerative diseases in HD model cells and mice. They also found that SGTA associates with a large proportion of the huntingtin in cells models of HD that we would expect to be in the aggregated stage. Even though aggregatesaggregate Lumps of protein that form inside cells in Huntington’s disease and some other degenerative diseases act like magnets for cochaperones like SGTA, the co-chaperonechaperone chaperone proteins help other proteins to fold correctly, and can protect proteins against damage needs to be in range of the aggregateaggregate Lumps of protein that form inside cells in Huntington’s disease and some other degenerative diseases. The authors propose SGTA is acting on the aggregateaggregate Lumps of protein that form inside cells in Huntington’s disease and some other degenerative diseases and even identify the region of SGTA molecule that sticks to the huntingtin clumps. Now we’ve identified a hall monitor capable of reprimanding huntingtin before it takes it to the chaperonechaperone chaperone proteins help other proteins to fold correctly, and can protect proteins against damage.
Strengthening the Frontlines
The big question now that we know SGTA interacts with huntingtin clumps is whether we can use it as a target for developing new medicines for HD. Researchers increased the amount of SGTA in HD model cells to see if it would reduce huntingtin clumps or cause more chaos. They found that increasing SGTA made expanded huntingtin less aggregated and more soluble. This suggests that SGTA isn’t just getting stuck on the huntingtin magnet but is intentionally acting on sneaky huntingtin.

Boosting SGTA to change huntingtin solubility is a major finding. Huntingtin aggregatesaggregate Lumps of protein that form inside cells in Huntington’s disease and some other degenerative diseases are big insoluble protein clumps, and SGTA overexpression shifts expanded huntingtin toward a more soluble state. SGTA seems to specifically target small immature aggregatesaggregate Lumps of protein that form inside cells in Huntington’s disease and some other degenerative diseases rather than large mature ones. Because of this preference, SGTA may help determine whether immature or mature aggregatesaggregate Lumps of protein that form inside cells in Huntington’s disease and some other degenerative diseases should be targeted to treat HD.
What’s Next
This study shows the importance of trusting the hall monitors of the cell. Researchers found not only that SGTA binds to expanded huntingtin, but also that when you increase the amount of SGTA in the cell, the properties of expanded huntingtin change to a less aggregated state. This suggests that SGTA is acting on expanded huntingtin to decrease its aggregation.
Where do we go from here? Increasing our cellular hall monitors shows promise as a therapeutic target, but there is still lots of work to be done. What is SGTA doing to decrease aggregation? Why is increasing the amount of it effective? Is it working with a chaperonechaperone chaperone proteins help other proteins to fold correctly, and can protect proteins against damage or acting all on its own? These are vital questions for future research.
Summary
- Chaperoneschaperone chaperone proteins help other proteins to fold correctly, and can protect proteins against damage target misbehaving proteins to prevent further chaos to the cell.
- In HD, expanded huntingtin misbehaves into aggregatesaggregate Lumps of protein that form inside cells in Huntington’s disease and some other degenerative diseases that are not effectively managed by chaperoneschaperone chaperone proteins help other proteins to fold correctly, and can protect proteins against damage.
- Early studies find the co-chaperonechaperone chaperone proteins help other proteins to fold correctly, and can protect proteins against damage SGTA to interact with expanded huntingtin.
- Increasing the amount of SGTA reduces the aggregation of expanded huntingtin.
- Co-chaperoneschaperone chaperone proteins help other proteins to fold correctly, and can protect proteins against damage may serve as an underutilized therapeutic target for managing HD.
Learn More
Meet this 2025 HDBuzz Writing Competition Winner

Chloe is a PhD candidate in the lab of Dr. Emily Sontag in the department of Biological Sciences at Marquette University. Her dissertation work focuses on how quality control proteins interact with the huntingtin proteinhuntingtin protein The protein produced by the HD gene. associated with HD when mutated. She hope this work can contribute to future therapeuticstherapeutics treatments.
This year, the HDBuzz Prize is brought to you by the Hereditary Disease Foundation (HDF), who are sponsoring this year’s competition.

For more information about our disclosure policy see our FAQ…


